vs

Side-by-side financial comparison of Acadian Asset Management Inc. (AAMI) and HUTCHMED (China) Ltd (HCM). Click either name above to swap in a different company.

HUTCHMED (China) Ltd is the larger business by last-quarter revenue ($270.8M vs $172.2M, roughly 1.6× Acadian Asset Management Inc.). Acadian Asset Management Inc. runs the higher net margin — 20.2% vs 0.7%, a 19.4% gap on every dollar of revenue. On growth, Acadian Asset Management Inc. posted the faster year-over-year revenue change (2.6% vs -16.5%).

United Asset Management was an American holding company headquartered in Boston, Massachusetts.

HUTCHMED (China) Ltd is a biopharmaceutical firm focused on discovering, developing and commercializing targeted and immunotherapies for oncology and immunological diseases. It operates across China and global markets, with multiple marketed oncology drugs and a robust pipeline of late-stage clinical candidates addressing unmet patient needs.

AAMI vs HCM — Head-to-Head

Bigger by revenue
HCM
HCM
1.6× larger
HCM
$270.8M
$172.2M
AAMI
Growing faster (revenue YoY)
AAMI
AAMI
+19.2% gap
AAMI
2.6%
-16.5%
HCM
Higher net margin
AAMI
AAMI
19.4% more per $
AAMI
20.2%
0.7%
HCM

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
AAMI
AAMI
HCM
HCM
Revenue
$172.2M
$270.8M
Net Profit
$34.7M
$2.0M
Gross Margin
37.7%
Operating Margin
33.3%
-13.2%
Net Margin
20.2%
0.7%
Revenue YoY
2.6%
-16.5%
Net Profit YoY
-18.4%
-83.6%
EPS (diluted)
$0.97
$0.00

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AAMI
AAMI
HCM
HCM
Q4 25
$172.2M
$270.8M
Q3 25
$144.2M
Q2 25
$127.4M
$277.7M
Q1 25
$119.9M
$324.5M
Q4 24
$167.8M
Q3 24
$123.1M
Q2 24
$109.0M
$305.7M
Q1 24
$105.7M
Net Profit
AAMI
AAMI
HCM
HCM
Q4 25
$34.7M
$2.0M
Q3 25
$15.1M
Q2 25
$10.1M
$455.0M
Q1 25
$20.1M
$11.9M
Q4 24
$42.5M
Q3 24
$16.9M
Q2 24
$11.0M
$25.8M
Q1 24
$14.6M
Gross Margin
AAMI
AAMI
HCM
HCM
Q4 25
37.7%
Q3 25
Q2 25
0.1%
Q1 25
48.0%
Q4 24
Q3 24
Q2 24
41.1%
Q1 24
Operating Margin
AAMI
AAMI
HCM
HCM
Q4 25
33.3%
-13.2%
Q3 25
18.4%
Q2 25
12.7%
-1.3%
Q1 25
26.6%
-5.0%
Q4 24
38.7%
Q3 24
21.9%
Q2 24
18.9%
-9.0%
Q1 24
21.7%
Net Margin
AAMI
AAMI
HCM
HCM
Q4 25
20.2%
0.7%
Q3 25
10.5%
Q2 25
7.9%
163.8%
Q1 25
16.8%
3.7%
Q4 24
25.3%
Q3 24
13.7%
Q2 24
10.1%
8.4%
Q1 24
13.8%
EPS (diluted)
AAMI
AAMI
HCM
HCM
Q4 25
$0.97
$0.00
Q3 25
$0.42
Q2 25
$0.28
$0.52
Q1 25
$0.54
$0.01
Q4 24
$1.11
Q3 24
$0.45
Q2 24
$0.29
$0.03
Q1 24
$0.37

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AAMI
AAMI
HCM
HCM
Cash + ST InvestmentsLiquidity on hand
$1.4B
Total DebtLower is stronger
$200.0M
$93.2M
Stockholders' EquityBook value
$1.2B
Total Assets
$677.0M
$1.8B
Debt / EquityLower = less leverage
0.08×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AAMI
AAMI
HCM
HCM
Q4 25
$1.4B
Q3 25
Q2 25
$1.4B
Q1 25
$836.1M
Q4 24
Q3 24
Q2 24
$802.5M
Q1 24
Total Debt
AAMI
AAMI
HCM
HCM
Q4 25
$200.0M
$93.2M
Q3 25
Q2 25
$93.4M
Q1 25
$82.8M
Q4 24
$275.0M
Q3 24
Q2 24
$82.1M
Q1 24
Stockholders' Equity
AAMI
AAMI
HCM
HCM
Q4 25
$1.2B
Q3 25
Q2 25
$1.2B
Q1 25
$759.9M
Q4 24
Q3 24
Q2 24
$740.1M
Q1 24
Total Assets
AAMI
AAMI
HCM
HCM
Q4 25
$677.0M
$1.8B
Q3 25
$751.4M
Q2 25
$672.3M
$1.8B
Q1 25
$677.3M
$1.3B
Q4 24
$703.2M
Q3 24
$555.2M
Q2 24
$533.1M
$1.3B
Q1 24
$544.9M
Debt / Equity
AAMI
AAMI
HCM
HCM
Q4 25
0.08×
Q3 25
Q2 25
0.08×
Q1 25
0.11×
Q4 24
Q3 24
Q2 24
0.11×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AAMI
AAMI
HCM
HCM
Operating Cash FlowLast quarter
$-2.4M
$8.2M
Free Cash FlowOCF − Capex
$3.4M
FCF MarginFCF / Revenue
1.2%
Capex IntensityCapex / Revenue
1.8%
Cash ConversionOCF / Net Profit
-0.07×
4.21×
TTM Free Cash FlowTrailing 4 quarters
$-96.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AAMI
AAMI
HCM
HCM
Q4 25
$-2.4M
$8.2M
Q3 25
$-23.9M
Q2 25
$61.6M
$-72.9M
Q1 25
$-48.8M
$40.3M
Q4 24
$55.8M
Q3 24
$69.6M
Q2 24
$45.7M
$-39.8M
Q1 24
$-40.4M
Free Cash Flow
AAMI
AAMI
HCM
HCM
Q4 25
$3.4M
Q3 25
Q2 25
$-82.2M
Q1 25
$32.5M
Q4 24
Q3 24
Q2 24
$-49.9M
Q1 24
FCF Margin
AAMI
AAMI
HCM
HCM
Q4 25
1.2%
Q3 25
Q2 25
-29.6%
Q1 25
10.0%
Q4 24
Q3 24
Q2 24
-16.3%
Q1 24
Capex Intensity
AAMI
AAMI
HCM
HCM
Q4 25
1.8%
Q3 25
Q2 25
3.3%
Q1 25
2.4%
Q4 24
Q3 24
Q2 24
3.3%
Q1 24
Cash Conversion
AAMI
AAMI
HCM
HCM
Q4 25
-0.07×
4.21×
Q3 25
-1.58×
Q2 25
6.10×
-0.16×
Q1 25
-2.43×
3.38×
Q4 24
1.31×
Q3 24
4.12×
Q2 24
4.15×
-1.54×
Q1 24
-2.77×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons